Gastroenterology Research · Published 2026-06-01 · DOI 10.14740/gr2136
Jonathan Weng, Anderson Huang, Tamiru B. Berake, Sarah L. Chen, Brian M. Yan, Raffi Karagozian
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Weng, J., Huang, A., Berake, T., et al. (2026). Glucagon-Like Peptide-1 Receptor Agonist Therapy Reduces Fibrosis-4 Index in Metabolic Dysfunction-Associated Steatotic Liver Disease. Gastroenterology Research. https://doi.org/10.14740/gr2136